The role of fiber supplementation in the treatment of irritable bowel syndrome: A systematic review and meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 9, 2015, Pages 1002-1010

  Nagarajan, Neeraja ^a,b   Morden, Amanda ^a   Bischof, Danielle ^a,b   King, Elizabeth A ^a,b   Kosztowski, Martin ^a   Wick, Elizabeth C ^b   Stein, Ellen M ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

fiber supplementation; functional bowel disease; irritable bowel syndrome

Indexed keywords

ISPAGULA; METHYLCELLULOSE; PLACEBO; POLYCARBOPHIL CALCIUM;

ABDOMINAL PAIN; ARTHRALGIA; BACKACHE; CEREAL; CONSTIPATION; CROSSOVER PROCEDURE; DIARRHEA; DIET SUPPLEMENTATION; DIETARY FIBER; DISEASE SEVERITY; DYSPHAGIA; FATIGUE; FLATULENCE; HUMAN; IRRITABLE COLON; LINSEED; MAIZE; META ANALYSIS; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PELVIC PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; VEGETABLE; WHEAT BRAN; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COMPLICATION; DIET THERAPY; DIETARY SUPPLEMENT; IRRITABLE BOWEL SYNDROME; ODDS RATIO; SEVERITY OF ILLNESS INDEX; SOLUBILITY; THERAPEUTIC USE; TREATMENT OUTCOME;

ABDOMINAL PAIN; CHI-SQUARE DISTRIBUTION; DIETARY FIBER; DIETARY SUPPLEMENTS; HUMANS; IRRITABLE BOWEL SYNDROME; ODDS RATIO; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SOLUBILITY; TREATMENT OUTCOME;

EID: 84938934167     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000425     Document Type: Review

References (55)

1. Bijkerk CJ, de Wit NJ, Muris JW, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ 2009; 339: b3154
2. Mayer EA. Irritable bowel syndrome. N Engl J Med 2008; 358: 1692-1699
3. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-2131
4. Talley NJ A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord 2006; 6: 72-78
5. Jones R. Treatment of irritable bowel syndrome in primary care. BMJ 2008; 337: a2213
6. Hillilä MT, Färkkilä MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther 2004; 20: 339-345
7. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491
8. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 78-82
9. Bijkerk CJ, Muris JW, Knottnerus JA, Hoes AW, de Wit NJ. Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004; 19: 245-251
10. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-654
11. Dalton CB, Drossman DA. Diagnosis and treatment of irritable bowel syndrome. Drugs Today (Barc) 1998; 34: 585-592
12. Dogan UB, Ünal S. Kruis scoring system and Manning's criteria in diagnosis of irritable bowel syndrome: is it better to use combined? Acta Gastroenterol Belg 1996; 59: 225-228
13. Ford AC, Guyatt GH, Talley NJ, Moayyedi P. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome. Am J Gastroenterol 2010; 105: 280-288
14. Rubin G, De Wit N, Meineche-Schmidt V, Seifert B, Hall N, Hungin P the diagnosis of IBS in primary care: consensus development using nominal group technique. Fam Pract 2006; 23: 687-692
15. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-1798
16. Brandt LJ, Bjorkman D, Fennerty MB, Locke GR, Olden K, Peterson W, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97 (11 Suppl): S7-S26
17. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011. CD003460
18. Miller V, Lea R, Agrawal A, Whorwell PJ. Bran and irritable bowel syndrome: the primary-care perspective. Dig Liver Dis 2006; 38: 737-740
19. Paterson WG, Thompson WG, Vanner SJ, Faloon TR, Rosser WW, Birtwhistle RW, et al. Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants. CMAJ 1999; 161: 154-160
20. Bennett WG, Cerda JJ. Benefits of dietary fiber. Myth or medicine? Postgrad Med 1996; 99: 153-156, 166-168, 171-172 passim
21. Longstreth GF, Fox DD, Youkeles L, Forsythe AB, Wolochow DA. Psyllium therapy in the irritable bowel syndrome A double-blind trial. Ann Intern Med 1981; 95: 53-56
22. Toskes PP, Connery KL, Ritchey TW. Calcium polycarbophil compared with placebo in irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 87-92
23. Jalihal A, Kurian G. Ispaghula therapy in irritable bowel syndrome: improvement in overall well-being is related to reduction in bowel dissatisfaction. J Gastroenterol Hepatol 1990; 5: 507-513
24. Cann PA, Read NW, Holdsworth CD. What is the benefit of coarse wheat bran in patients with irritable bowel syndrome? Gut 1984; 25: 168-173
25. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1988; 95: 232-241
26. Rees GA, Trevan M, Davies GJ. Dietary fibre modification and the symptoms of irritable bowel syndrome-A review. J Hum Nut Diet 1994; 7: 179-189
27. Moayyedi P, Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al the effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-Analysis. Am J Gastroenterol 2014; 109: 1367-1374
28. Ford AC, Talley NJ, Spiegel BM, Foxx-Orenstein AE, Schiller L, Quigley EM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and metaanalysis. BMJ 2008; 337: a2313
29. Nagarajan N, Morden A, Bischof D, King E, Kosztowski M, Wick E, et al the role of dietary fibers in the treatment of irritable bowel syndrome: a systematic review and meta-Analysis. PROSPERO 2014; CRD42014010489
30. The Nordic Cochrane Centre The Cochrane Collaboration. Review Manager (RevMan) [Computer program] Version 53. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014
31. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 510 [updated March 2011] the Cochrane Collaboration
32. Cockerell KM, Watkins AS, Reeves LB, Goddard L, Lomer MC. Effects of linseeds on the symptoms of irritable bowel syndrome: a pilot randomised controlled trial. J Hum Nutr Diet 2012; 25: 435-443
33. Everitt H, Moss-Morris R, Sibelli A, Tapp L, Coleman N, Yardley L, et al. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website. BMC Gastroenterol 2013; 13: 68
34. Golechha AC, Chadda VS, Chadda S, Sharma SK, Mishra SN. Role of ispaghula husk in the management of irritable bowel syndrome (a randomized double-blind crossover study). J Assoc Physicians India 1982; 30: 353-355
35. Nayak AK, Karnad DR, Abraham P, Mistry FP. Metronidazole relieves symptoms in irritable bowel syndrome: the confusion with so-called' chronic amebiasis'. Indian J Gastroenterol 1997; 16: 137-139
36. Prior A, Whorwell PJ. Double blind study of ispaghula in irritable bowel syndrome. Gut 1987; 28: 1510-1513
37. Ritchie JA, Truelove SC. Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk. Br Med J 1979; 1: 376-378
38. Arffmann S, Andersen JR, Hegnhøj J, Schaffalitzky de Muckadell OB, Mogensen NB, Krag E the effect of coarse wheat bran in the irritable bowel syndrome A double-blind cross-over study. Scand J Gastroenterol 1985; 20: 295-298
39. Cook IJ, Irvine EJ, Campbell D, Shannon S, Reddy SN, Collins SM. Effect of dietary fiber on symptoms and rectosigmoid motility in patients with irritable bowel syndrome A controlled, crossover study. Gastroenterology 1990; 98: 66-72
40. Diaz-Rubio M, De Onis Sanz M, Enriquez Gonzalez L, Esteban Bernaldez JM. Effects of wheat bran in the irritable bowel syndrome. An Med Interna 1985; 2: 420-422
41. Fowlie S, Eastwood MA, Prescott R. Irritable bowel syndrome: assessment of psychological disturbance and its influence on the response to fibre supplementation. J Psychosom Res 1992; 36: 175-180
42. Kruis W, Weinzierl M, Schüssler P, Holl J. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. Digestion 1986; 34: 196-201
43. Manning AP, Heaton KW, Harvey RF. Wheat fibre and irritable bowel syndrome A controlled trial. Lancet 1977; 2: 417-418
44. Rees G, Davies J, Thompson R, Parker M, Liepins P. Randomisedcontrolled trial of a fibre supplement on the symptoms of irritable bowel syndrome. J R Soc Promot Health 2005; 125: 30-34
45. Snook J, Shepherd HA. Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994; 8: 511-514
46. Soltoft J, Krag B, Gudmand-Hoyer E, Kristensen E, Wulff HR A doubleblind trial of the effect of wheat bran on symptoms of irritable bowel syndrome. Lancet 1976; 1: 270-272
47. Lucey MR, Clark ML, Lowndes J, Dawson AM. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study. Gut 1987; 28: 221-225
48. Nigam P, Kapoor KK, Rastog CK, Kumar A, Gupta AK. Different therapeutic regimens in irritable bowel syndrome. J Assoc Physicians India 1984; 32: 1041-1044
49. Müller-Lissner S. General geriatrics and gastroenterology: constipation and faecal incontinence. Best Pract Res Clin Gastroenterol 2002; 16: 115-133
50. Spiller RC. Pharmacology of dietary fibre. Pharmacol Ther 1994; 62: 407-427
51. Eswaran S, Muir J, Chey WD. Fiber and functional gastrointestinal disorders. Am J Gastroenterol 2013; 108: 718-727
52. Tilg H, Moschen AR. Food, immunity, and the microbiome. Gastroenterology 2015; 148: 1107-1119
53. Arthurs Y, Fielding JF. Double blind trial of ispaghula/poloxamer in the irritable bowel syndrome. Ir Med J 1983; 76: 253
54. Aller R, de Luis DA, Izaola O, la Calle F, del Olmo L, Fernandez L, et al. Effects of a high-fiber diet on symptoms of irritable bowel syndrome: a randomized clinical trial. Nutrition 2004; 20: 735-737
55. Villagrasa M, Boix J, Humbert P, Quer JC. Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome. Ital J Gastroenterol 1991; 23 (8 Suppl 1): 67-70